James Hartman

2010, Present Senior Equity Analyst, Portfolio Manager at Virelle. Responsible for analyzing equities covering the biopharmaceutical, high tech, and consumer products sectors and providing strategic investment advice.

2000 - 2010, Equity Analyst, Newman Capital Corporation. Focused on the biotechnology and pharmaceutical industries, researching cutting-edge industry developments and potential market opportunities. Evaluated corporate financials, analyzed stock valuations, and analyzed public company financial reports, industry data, and the global macroeconomic environment to help the firm's clients make accurate investment decisions.

1995 - 2000, worked as a researcher at Tate Securities Co. Responsible for writing market research reports, analyzing industry trends and specific stock performance. Supported senior analysts in stock valuation and company financial analysis, and provided basic data support for the team.